Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for Refractory Diabetic Macular Edema
NCT03821168Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2019
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of erythropoietin in diabetic macular edema (DME), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
erythropoietin
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03821168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03821168.